OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $156,990 Invested

2012

Washington University in St. Louis

Nigel Cairns, PhD, FRCPath

Restoring progranulin in frontotemporal disease

  • Funding Amount: $156,990
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Other
  • Status: Closed